Ganli Pharmaceutical (603087.SH): Ganjing Insulin Injection receives drug registration approval in Honduras.

Zhixin Finance APP News, Ganli Pharmaceutical (603087.SH) announced that recently, the company has received the approved registration certificate for Ganjing insulin injection from the National Medicines Supervision Administration of Honduras. Ganjing insulin is a basal long-acting insulin that is injected subcutaneously once a day, with a duration of blood sugar-lowering effect lasting for 24 hours. It has the characteristics of a long duration of action, steady blood drug concentration without peaks, and steady control of blood sugar.